Nagamura-Inoue, Tokiko http://orcid.org/0000-0002-6556-2894
Kato, Seiko
Najima, Yuho
Isobe, Masamichi
Doki, Noriko
Yamamoto, Hisashi
Uchida, Naoyuki
Takahashi, Atsuko
Hori, Akiko
Nojima, Masanori
Ohashi, Kazuteru
Nagamura, Fumitaka
Tojo, Arinobu
Clinical trials referenced in this document:
Documents that mention this clinical trial
Immunological influence of serum-free manufactured umbilical cord-derived mesenchymal stromal cells for steroid-resistant acute graft-versus-host disease
https://doi.org/10.1007/s12185-022-03408-7
Funding for this research was provided by:
Japan Agency for Medical Research and Development (17bk0104070h0001/18bk0104070h0002/19bk0104070h0003 / 20bk01041h0001/21bk0104109h0002, 21be0804004h0001)
Article History
Received: 12 February 2022
Accepted: 13 June 2022
First Online: 30 July 2022
Declarations
:
: The study was partially supported by the joint research study of the University of Tokyo with Rohto Pharmaceutical Co. Ltd. in the development of culture medium and processing (December 2014, December to March 2020) and the joint study of the University of Tokyo with Human Life Cord Japan Inc. in the development of banking and clinical application (September 2017–). Nagamura-Inoue is the senior medical advisor of Human Life Cord Japan Inc.